Results 101 to 110 of about 66,176 (317)

Unveiling the Therapeutic Potential of Atractylis aristata Batt. Aqueous Extract: Anti‐inflammatory, Antioxidant, Antibacterial, Sedative Activities & Phytochemical Profiling

open access: yesChemistryOpen, Volume 14, Issue 9, September 2025.
This study evaluates the pharmacological properties of the aqueous extract of Atractylis aristata, focusing on its antioxidant, anti‐inflammatory, antibacterial, and sedative activities. Phytochemical analysis identifies bioactive compounds, while in vitro and in vivo tests demonstrate its therapeutic potential in addressing oxidative stress ...
Asma Abid   +14 more
wiley   +1 more source

Redefining the practical roles of psychiatrists in epilepsy care: A framework for collaboration in Japan

open access: yesPsychiatry and Clinical Neurosciences Reports, Volume 4, Issue 3, September 2025.
Abstract Psychiatric symptoms are prevalent among people with epilepsy (PWE), yet psychiatric care remains underdeveloped in epilepsy services worldwide. Many psychiatrists lack sufficient familiarity with epilepsy, contributing to gaps in care. Japan, however, has a distinctive history where psychiatrists played a central role in epilepsy treatment ...
Go Taniguchi   +4 more
wiley   +1 more source

Chloride-dependent enhancement by barbiturates of gamma-aminobutyric acid receptor binding

open access: yesJournal of Neuroscience, 1982
Barbiturates enhance GABA receptor (sodium-independent) binding at 0°C to bovine brain membranes about 2-fold in chloride-containing buffer but not in chloride-free phosphate or Tris/ citrate buffer.
R. Olsen, A. Snowman
semanticscholar   +1 more source

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes

open access: yesAnnals of Human Genetics, Volume 89, Issue 5, Page 398-405, September 2025.
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott   +3 more
wiley   +1 more source

Barbiturates for acute traumatic brain injury.

open access: yesCochrane Database of Systematic Reviews, 2012
Ian W. Roberts, E. Sydenham
semanticscholar   +2 more sources

Characterization of \([^3H]\)Phenobarbital Binding to Rat Brain Membranes [PDF]

open access: yes, 1984
The binding of \([^3H]\)phenobarbital to rat brain membranes was studied in order to determine its characteristics and specificity. The binding reaction was rapid and occurred at sites of low affinity. \((K_d = 700 μM)\) and very high density \((B_{max} =
Klotz, K.-N.   +3 more
core  

Gender and Overdose Risk Factors Among Clients Entering Residential Treatment for Opioid Use

open access: yesDrug and Alcohol Review, Volume 44, Issue 6, Page 1786-1804, September 2025.
ABSTRACT Introduction The period post‐residential treatment for opioid use is associated with heightened risk of overdose. The current study aims to: (i) describe characteristics of men and women attending residential treatment for primary opioid use; (ii) identify classes of clients based on primary opioid and other substance/s of concern and (iii ...
Chloe J. Haynes   +9 more
wiley   +1 more source

Pattern of drugs of abuse identified in chemical samples [PDF]

open access: yes, 2010
OBJECTIVE: To determine the pattern of drugs of abuse in urine and blood samples processed at referral laboratory in Pakistan so that information on the type of drugs used can be identified and used for ready reference for future strategy.
Dar, Farhan Javed   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy